Researchers reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ...

Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

The question now is how to best serve the millions who, freed from a lifetime of yo-yo dieting, are re-engaging with their ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

As millions of Americans evaluate their health plan options during open enrollment season, a recent survey found that 43% of people regret a health decision they’ve made because of misleading ...